Shaun Bagai - CEO of RenovoRX
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Podcast Index
Browse podcasts by category, open recent episodes, and download audio to listen offline.
BioBoss
John Simboli
Le journal d'Europe 1
Europe 1
Remote Work Tech Brief By HackerNoon
HackerNoon
The Rooted DC- Reclaim Your Legitimacy
Dr. Alexandra Swenson-Ridley
Finance Tech Brief By HackerNoon
HackerNoon
Tech Stories Tech Brief By HackerNoon
HackerNoon
Web3 Tech Brief By HackerNoon
HackerNoon
Business Tech Brief By HackerNoon
HackerNoon
Let's Appreciate
Kyla Scanlon
Ekantik Vartalap
Bhajan Marg
BFM Bourse
BFM Business
ITM Trading Podcast
The Daniela Cambone Show and Taylor Made Economics
Discover Crypto
HIT Network
Mornings with Simi
Curiouscast
RadioPirate FREE
RadioPirate
Patriot Radio News Hour
Joe Jaquint
Der Amerika-Effekt – Donald Trump und die neue Weltordnung
WELT
Macro Voices
Hedge Fund Manager Erik Townsend
The EarthWorks Podcast
EarthWorks
Becker’s Healthcare Podcast
Becker's Healthcare
Podcast de Itnig: Historias de startups
itnig
Inversión Dividendos
Carlos García
Company Interviews
Crux Investor
Flash Stock Reports (Video)
Flash by StockSentinel.AI
IBKR Podcasts
Interactive Brokers Podcast
Podcasts – RealAgriculture
RealAgriculture
The MFA Podcast
Marina Press Granger
Win With Paid Ads
Ashley Brock
Faster, Please! — The Podcast
James Pethokoukis
Trascendencia Financiera con César Tánchez
Trascendencia Financiera con César Tánchez
Green Ticker Tales
Greentickertales
AgriTalk AM & PM
AgriTalk AM & PM
Squawk on the Street
CNBC
Financial Issues
BizTalkPodcasts
How To Run Profitable Retreats
Leni Cavazos
The Charity Shop Chat
The Charity Retail Consultancy
Business
John Simboli
Shaun Bagai, CEO of RenovoRX, shares his insights about leadership in biopharma and how RenovoRX is working to develop targeted oncology therapies and commercialize its FDA cleared drug delivery device.
Hyung Heon Kim, CEO of MetaVia, shares his insights about leadership in biopharma and how MetaVia is working to transform cardiometabolic disease.
David Southwell, CEO of Volastra Therapeutics, shares his insights about leadership in biopharma and how Volastra is working to discover and develop oncology therapeutics targeting chromosomal instability, a vulnerabilit...
Stacy Lindborg, CEO of Imunon, shares her insights about leadership in biopharma and how Imunon is working to develop medicines that harness the building blocks of life to work in harmony with the body's immune system.
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2026
Michael Cloonan, CEO of Sionna Therapeutics, shares his insights about leadership in biopharma and how Sionna is working to restore the cystic fibrosis transmembrane conductance regulator for people living with cystic fi...
Erik van den Berg, CEO of Memo Therapeutics, shares his insights about leadership in biopharma and how Memo is working to develop antibodies to transform the lives of patients with viral infections and cancer.
Bruce Leuchter, CEO of Neurvati Neurosciences, shares his insights about leadership in biopharma and how Neurvati is working to advance drugs with the potential to improve the health and lives of people living with neuro...
Todd Harris, CEO of Tyra Biosciences, shares his insights about leadership in biopharma and how Tyra is working to develop precision medicines that target large fibroblast growth factor receptor biology.
Eduardo Bravo, CEO of Citryll, shares his insights about leadership in biopharma and how Citryll is working to transform the approach to treating immune mediated inflammatory diseases.
Abbas Kazimi, CEO of Nimbus Therapeutics, shares his insights about leadership in biopharma and how Nimbus is working to design and develop small molecule medicines capable of improving patients' lives.
Derek Adams, CEO of Stellular Bio, shares his insights about leadership in biopharma and how Stellular Bio is working to expand the reach of regenerative medicine.
Geoffrey Dow, CEO of 60 Degrees Pharmaceuticals, shares his insights about leadership in biopharma and how 60 Degrees Pharmaceuticals is working to develop vital medicines to treat and prevent infectious diseases.
Jorge Santos da Silva, co-founder and CEO of MoonLake Immunotherapeutics, shares his insights about leadership in biopharma and how MoonLake Immunotherapeutics is working to develop life changing therapies for people liv...
Vlad Vitoc, founder and CEO of MAIA Biotechnology, shares his insights with BioBoss host John Simboli about leadership in biopharma and how MAIA is working to develop and deliver innovative medicines to improve and exten...
“What leads a leader?”As you listen to clips from BioBoss podcasts, you may hear remarkably consistent ideas about leadership, as shared by BioBoss guests, who reflect on their younger years and how those experiences sha...
BioBoss podcast host John Simboli reflects on Seasons 1-6 and invites listeners to Season 7 starting in January 2025
Sam Clark, founder and CEO of Terran Biosciences, shares his insights with BioBoss host John Simboli about leadership in biopharma and how Terran is working to develop therapeutics and technologies for patients with neur...
Iain Kilty, CEO of Sitryx, shares his insights about leadership in biopharma and how Sitryx is working to alter immune cell metabolism to resolve disease
Steve Uden, co-founder and CEO of RallyBio, shares his insights about leadership in biopharma and how Rallybio is working to to profoundly change the odds for patients living with rare diseases.
Fill in the form below. Make sure to select both Country and Genres.
Send us a message below. We will get back to you within 24 hours.